Drug Trial Radar · NCT06841926
Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males
Last checked: Nov 20, 2026Latest source record: May 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Feb 20, 2025
Primary completion
Apr 18, 2025
Study completion Apr 18, 2025
Sponsor
- Lead sponsor
- Nanjing Zenshine PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Feb 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Study to evaluate the pharmacokinetics and relative bioavailability of metabolites in healthy Chinese adult males
Conditions
- Respiratory Viral Infection
Interventions
ZX-7101A dry suspensionDrug
Test formulation (T) : ZX-7101A dry suspension Specification: 10 mg/ bag Dosage:40 mg (4 bags)、 once
ZX-7101A tabletOther
Reference formulation (R): ZX-7101A tablet Specification: 40 mg/ tablet Dosage:40 mg (1 tablet)、 once
Primary outcomes
What the sponsor says the trial is designed to measure.
- The pharmacokinetic parameters Cmax of the active metabolite ZX-7101 (parent drug)Time frame: From Day1 up to Day 36
- The pharmacokinetic parameters AUC0-t of the active metabolite ZX-7101 (parent drug)Time frame: From Day1 up to Day 36
- The pharmacokinetic parameters AUC0-inf of the active metabolite ZX-7101 (parent drug)Time frame: From Day1 up to Day 36
- Relative bioavailability of the active metabolite ZX-7101 (parent drug)Time frame: From Day1 up to Day 36
Locations
1 site in 1 country. Site status is shown where the registry gives one.
West China Second University Hospital, Sichuan University and Children's Hospital Zhejiang University School of Medicine
Chengdu, Sichuan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.